Allopharm — Biotechnology company

The main activities of Allopharm

Allopharm is engaged in the search for, development and commercialization of new medicinal substances, the prototypes of which are based on the active components of insect immune systems, with antiviral, antitumor and antibacterial action. Some of the preparations developed by the company, obtained through complete chemical synthesis or biosynthesis in insect cultures, have already found application in medicine and dermatocosmetology.

Studying insect immune systems as the basis of scientific discoveries

The creation of technologies for the introduction of newly acquired knowledge into modern medicine

Cooperation with Russian and foreign institutions in the field of developing new methods of treatment and disease prevention

Intellectual property

The company's developments are protected by patents

Research Base

The research behind our developments has been carried out for more than 20 years

Our publications

Our findings undergo serious scientific examination, we publish in Web of Science journal

Scientific developments

The most promising developments of Allopharm are based on fundamental research by its researchers in the field of insect biopharmacology and immunology